Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma

Blood

Volumn 113, Issue 9, 2009, Pages 1899-1905

  Colt, Joanne S ^a   Rothman, Nathaniel ^a   Severson, Richard K ^b   Hartge, Patricia ^a   Cerhan, James R ^c   Chatterjee, Nilanjan ^a   Cozen, Wendy ^d   Morton, Lindsay M ^a   De Roos, Anneclaire J ^e   Davis, Scott ^e   Chanock, Stephen ^a   Wang, Sophia S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c Mayo Clinic College of Medicine   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORDANE; GAMMA INTERFERON RECEPTOR 1; INTERLEUKIN 10; INTERLEUKIN 16; INTERLEUKIN 4; INTERLEUKIN 8; ORGANOCHLORINE DERIVATIVE;

5' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER REGISTRY; CANCER RISK; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DUST; ENVIRONMENTAL EXPOSURE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; IMMUNE RESPONSE GENE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PLASMA CELL; PRIORITY JOURNAL;

EID: 61849090772     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-04-153858     Document Type: Article

References (39)

1. Bertazzi A, Pesatori AC, Consonni D, Tironi A, Landi MT, Zocchetti C. Cancer incidence in a population accidentally exposed to 2,3,7,8-tetra- chlorodibenzo-para-dioxin. Epidemiology. 1993;4:398-406.
2. Colt JS, Severson RK, Lubin J, et al. Organochlorines and carpet dust and non-Hodgkin lymphoma. Epidemiology. 2005;16:516-525.
3. Colt JS, Davis S, Severson RK, et al. Residential insecticide use and risk of non-Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev. 2006;15:251-257.
4. DeRoos AJ, Hartge P, Lubin JH, et al. Persistent organochlorine chemicals in plasma and risk of non-Hodgkin's lymphoma. Cancer Res. 2005;65:11214-11226.
5. Engel LS, Laden F, Andersen A, et al. Polychlorinated biphenyls in peripheral blood and non-Hodgkin's lymphoma: a report from three cohorts. Cancer Res. 2007;67:5545-5552.
6. Fingerhut MA, Halperin WE, Marlow DA, et al. Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. N Engl J Med. 1991; 324:212-218.
7. Hardell L, Eriksson M, Lindstrom G, et al. Case-control study on concentrations of organohalogen compounds and titers of antibodies to Epstein-Barr virus antigens in the etiology of non-Hodgkin lymphoma. Leuk Lymphoma. 2001;42:619-629.
8. Kogevinas M, Becher H, Benn T, et al. Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study. Am J Epidemiol. 1997;145:1061-1075.
9. Quintana PJE, Delfino RJ, Korrick S, et al. Adipose tissue levels of organochlorine pesticides and polychlorinated biphenyls and risk of non-Hodgkin's lymphoma. Environ Health Perspect. 2004;112:854-861.
10. Rothman N, Cantor KP, Blair A, et al. A nested case-control study of non-Hodgkin lymphoma and serum organochlorine residues. Lancet. 1997;350:240-244.
11. Thomas TL, Kang HK. Mortality and morbidity among Army Chemical Corps Vietnam veterans: a preliminary report. Am J Ind Med. 1990;18:665-673.
12. McConnachie PR, Zahalsky AC. Immune alterations in humans exposed to the termiticide technical chlordane. Arch Environ Health. 1992;47:295-301.
13. Tryphonas H. Immunotoxicity of polychlorinated biphenyls: present status and future considerations. Exp Clin Immunogenet. 1994;11:149-162.
14. Tryphonas H, Bondy G, Hodgen M, et al. Effects of cis-nonachlor, trans-nonachlor, and chlordane on the immune system of Sprague-Dawley rats following a 28-day oral (gavage) treatment. Food Chem Toxicol. 2003;41:107-118.
15. Van Den Heuvel RL, Koppen G, Staessen JA, et al. Immunologic biomarkers in relation to exposure markers of PCBs and dioxins in Flemish adolescents (Belgium). Environ Health Perspect. 2002;110:595-600.
16. Weisglas-Kuperus N, Sas TC, Koopman-Esseboom C, et al. Immunologic effects of background prenatal and postnatal exposure to dioxins and polychlorinated biphenyls in Dutch infants. Pediatr Res. 1995;38:404-410.
17. Weisglas-Kuperas N, Patandin S, Berbers GAM, et al. Immunologic effects of background exposure to polychlorinated biphenyls and dioxins in Dutch preschool children. Environ Health Perspect. 2000;108:1203-1207.
18. Cerhan JR, Ansell SM, Fredericksen ZS, et al. Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma. Blood. 2007;110:4455-4463.
19. Lan Q, Zheng T, Rothman N, et al. Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood. 2006;107:4101-4108.
20. Purdue MP, Lan Q, Kricker A, et al. Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study. Carcinogenesis. 2007;28:704-712.
21. Rothman N, Skibola CF, Wang S, et al. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the Interlymph Consortium. Lancet Oncol. 2006;7:27-38.
22. Skibola CF, Curry JD, Nieters A. Genetic susceptibility to lymphoma. Haematologica. 2007;92:960-969.
23. Wang SS, Cerhan JR, Hartge P, et al. Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma. Cancer Res. 2006;66:9771-9780.
24. Wang SS, Cozen W, Cerhan JR, et al. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors. Cancer Res. 2007;67:5042-5054.
25. Chatterjee N, Hartge P, Cerhan JR, et al. Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers. Cancer Epidemiol Biomarkers Prev. 2004;13:1415-1421.
26. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-1392.
27. Colt JS, Lubin J, Camann D, et al. Comparison of pesticide levels in carpet dust and self-reported pest treatment practices in four U.S. sites. J Expo Anal Environ Epidemiol. 2004;14:74-83.
28. Lubin JH, Colt JS, Camann D, et al. Epidemiologic evaluation of measurement data in the presence of detection limits. Environ Health Perspect. 2004;112:1691-1696.
29. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Polychlorinated dibenzo-para-dioxins and polychlorinated dibenzofurans. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 69. Lyon, France: IARC; 1997:1-631.
30. Van den Berg M, Birnbaum L, Bosveld AT, et al. Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDGs for humans and wildlife. Environ Health Perspect. 1998;106:775-792.
31. Lindstrom G, Hooper K, Petreas M, Stephens R, Gilman A. Workshop on perinatal exposure to dioxin-like compounds, I: summary. Environ Health Perspect. 1995;103(suppl 2):135-142.
32. Nagayama J, Tsuji H, Iida T, et al. Immunologic effects of perinatal exposure to dioxins, PCBs and organochlorine pesticides in Japanese infants. Chemosphere. 2007;67(suppl):S393-S398.
33. Cozen W, Cerhan JR, Martinez-Maza O, et al. The effect of atopy, childhood crowding, and other immune-related factors on non-Hodgkin lymphoma risk. Cancer Cause Control. 2007;18:821-831.
34. Skinnider BF, Kapp U, Mak TW. The role of interleukin 13 in classical Hodgkin lymphoma. Leukemia Lymphoma. 2002;43:1203-1210.
35. Bugawan TL, Mirel DB, Valdes AM, Panelo A, Pozzilli P, Erlich HA. Association and interaction of the IL4R, IL4, and IL13 loci with type 1 diabetes among Filipinos. Am J Hum Genet. 2003;72:1505-1514.
36. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promotor. Eur J Immunogenetics. 1997;24:1-8.
37. Zhang X, Hei P, Deng L, Lin J. Interleukin-10 gene promotor polymorphisms and their protein production in peritoneal fluid in patients with endometriosis. Mol Hum Reprod. 2007;13:135-140.
38. Breen EC, Boscardin WJ, Detels R, et al. Non-Hodgkins B cell lymphoma in persons with acquired immunodeficiency syndrome is associated with increased serum levels of IL10, or the IL10 promotor -592 C/C genotype. Clin Immunol. 2003;109:119-129.
39. Chan CC, Whitcup SM, Solomon D, Nussenblatt RB. Interleukin-10 in the vitreous of patients with primary intraocular lymphoma. Am J Ophthalmol. 1995;120:671-673.